MARIA SCUDERE: Open Payments
NPI 1962036509 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 24 payments from 12 companies in 2025. Trend: 2023 $708 · 2024 $579 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 1 | $59 |
| Novo Nordisk Inc | 3 | $55 |
| ABBVIE INC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Veozah, SPRAVATO, Wegovy, XIFAXAN, VOQUEZNA, PAXLOVID, LEQVIO, UBRELVY.
Industry payments across WV — which companies pay providers there.
